Three years after AbbVie stood at the edge of a major patent cliff with the loss of exclusivity for immunology ...
We just covered the Billionaire Joe Edelman’s 10 Stock Picks with Huge Upside Potential and Apogee Therapeutics, Inc. (NASDAQ ...
Reports First-Quarter Diluted EPS of $0.39 on a GAAP Basis, a Decrease of 45.8 Percent; Adjusted Diluted EPS of $2.65, an Increase of 7.7 Percent; These Results Include ...
The "direct-to" channel was a hot topic at the Asembia specialty pharmacy meeting this week in Las Vegas. The drug supply ...
Zacks Investment Research on MSN
Amgen's Q1 earnings top estimates, 16 drugs deliver double-digit gains
Amgen AMGN reported first-quarter adjusted earnings of $5.15 per share, which beat the Zacks Consensus Estimate of $4.73 per ...
By Kamal Choudhury and Christy Santhosh April 29 (Reuters) - AbbVie on Wednesday reported better-than-expected quarterly ...
Mounjaro generated $8.7 billion for Lilly in the first quarter of 2026, outperforming Merck's Keytruda, which posted sales of ...
Eli Lilly & Co.’s blockbuster diabetes drug Mounjaro has surpassed Merck & Co.’s cancer therapy Keytruda as the world’s ...
Osteoarthritis affects around 600 million people globally. It causes pain, stiffness and reduced joint function – most commonly in the knees, hands and hips. There’s currently no cure for ...
Getting ready for your first Zepbound (tirzepatide) dose? Injecting the medication is easier than it looks. Before you begin, take your pen or vial out of the refrigerator, wash your hands, and check ...
Semaglutide is a drug used for type 2 diabetes, weight loss, and more. Oral tablets and injections are both effective ways to take semaglutide. Oral tablets do not require the use of needles, but you ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results